UK: Taking stock of regenerative medicine
29/9/2011
The UK Government publishes its 'stock take' of regenerative medicine in the UK.
This report, developed in consultation with experts, and other Government partners, demonstrates the UK’s leading position in this area, with world-class science, a strict but facilitating regulatory framework, key infrastructure, and early commercial exploitation.
Author: Greer Deal, Director of Global Regulatory Services (GRS)